ANCCA/ATAD2 overexpression identifies breast cancer patients with poor prognosis, acting to drive proliferation and survival of triple-negative cells through control of B-Myb and EZH2

Ekaterina V. Kalashnikova, Alexey S. Revenko, Abigael T. Gemo, Nicolas P. Andrews, Clifford G Tepper, June X Zou, Robert Cardiff, Alexander D Borowsky, Hongwu Chen

Research output: Contribution to journalArticle

101 Citations (Scopus)

Abstract

Chromatin coregulators are important factors in tumorigenesis and cancer progression. ANCCA is an AAA+ ATPase and a bromodomain-containing nuclear coactivator for the estrogen and androgen receptors that is crucial for assembly of chromatin-modifying complexes and proliferation of hormone-responsive cancer cells. In this study, we show that ANCCA is overexpressed in >70% of breast tumors and that its high protein level correlates well with tumor histologic grades (P < 0.0001), highlighting ANCCA as a prognostic factor for poor overall survival and disease recurrence. Strikingly, high-level ANCCA correlated with triple-negative tumors that represent highly aggressive disease. Analysis of ANCCA transcript levels in multiple expression profiles of breast cancer identified ANCCA as a common signature gene, indicating that elevated transcripts also strongly correlate with tumor metastasis and poor survival. Biological and mechanistic investigations revealed that ANCCA is crucial for proliferation and survival of triple-negative/basal-like cancer cells and that it controls the expression of B-Myb, histone methyltransferase EZH2, and an Rb-E2F core program for proliferation, along with a subset of key mitotic kinesins and cell survival genes (IRS2, VEGF, and Akt1). In particular, ANCCA overexpression correlated strongly with EZH2 in tumors. Our results suggest that ANCCA may integrate multiple oncogenic programs in breast cancer, serving in particular as a prognostic marker and a therapeutic target for triple-negative cancers.

Original languageEnglish (US)
Pages (from-to)9402-9412
Number of pages11
JournalCancer Research
Volume70
Issue number22
DOIs
StatePublished - Nov 15 2010

Fingerprint

Breast Neoplasms
Neoplasms
Survival
Basal Cell Neoplasms
Kinesin
Chromatin Assembly and Disassembly
Androgen Receptors
Estrogen Receptors
Vascular Endothelial Growth Factor A
Genes
Chromatin
Adenosine Triphosphatases
Cell Survival
Carcinogenesis
Hormones
Neoplasm Metastasis
Recurrence
Proteins
Therapeutics

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

ANCCA/ATAD2 overexpression identifies breast cancer patients with poor prognosis, acting to drive proliferation and survival of triple-negative cells through control of B-Myb and EZH2. / Kalashnikova, Ekaterina V.; Revenko, Alexey S.; Gemo, Abigael T.; Andrews, Nicolas P.; Tepper, Clifford G; Zou, June X; Cardiff, Robert; Borowsky, Alexander D; Chen, Hongwu.

In: Cancer Research, Vol. 70, No. 22, 15.11.2010, p. 9402-9412.

Research output: Contribution to journalArticle

Kalashnikova, Ekaterina V. ; Revenko, Alexey S. ; Gemo, Abigael T. ; Andrews, Nicolas P. ; Tepper, Clifford G ; Zou, June X ; Cardiff, Robert ; Borowsky, Alexander D ; Chen, Hongwu. / ANCCA/ATAD2 overexpression identifies breast cancer patients with poor prognosis, acting to drive proliferation and survival of triple-negative cells through control of B-Myb and EZH2. In: Cancer Research. 2010 ; Vol. 70, No. 22. pp. 9402-9412.
@article{ad0fed4992f340f6b47c63c8421377d9,
title = "ANCCA/ATAD2 overexpression identifies breast cancer patients with poor prognosis, acting to drive proliferation and survival of triple-negative cells through control of B-Myb and EZH2",
abstract = "Chromatin coregulators are important factors in tumorigenesis and cancer progression. ANCCA is an AAA+ ATPase and a bromodomain-containing nuclear coactivator for the estrogen and androgen receptors that is crucial for assembly of chromatin-modifying complexes and proliferation of hormone-responsive cancer cells. In this study, we show that ANCCA is overexpressed in >70{\%} of breast tumors and that its high protein level correlates well with tumor histologic grades (P < 0.0001), highlighting ANCCA as a prognostic factor for poor overall survival and disease recurrence. Strikingly, high-level ANCCA correlated with triple-negative tumors that represent highly aggressive disease. Analysis of ANCCA transcript levels in multiple expression profiles of breast cancer identified ANCCA as a common signature gene, indicating that elevated transcripts also strongly correlate with tumor metastasis and poor survival. Biological and mechanistic investigations revealed that ANCCA is crucial for proliferation and survival of triple-negative/basal-like cancer cells and that it controls the expression of B-Myb, histone methyltransferase EZH2, and an Rb-E2F core program for proliferation, along with a subset of key mitotic kinesins and cell survival genes (IRS2, VEGF, and Akt1). In particular, ANCCA overexpression correlated strongly with EZH2 in tumors. Our results suggest that ANCCA may integrate multiple oncogenic programs in breast cancer, serving in particular as a prognostic marker and a therapeutic target for triple-negative cancers.",
author = "Kalashnikova, {Ekaterina V.} and Revenko, {Alexey S.} and Gemo, {Abigael T.} and Andrews, {Nicolas P.} and Tepper, {Clifford G} and Zou, {June X} and Robert Cardiff and Borowsky, {Alexander D} and Hongwu Chen",
year = "2010",
month = "11",
day = "15",
doi = "10.1158/0008-5472.CAN-10-1199",
language = "English (US)",
volume = "70",
pages = "9402--9412",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "22",

}

TY - JOUR

T1 - ANCCA/ATAD2 overexpression identifies breast cancer patients with poor prognosis, acting to drive proliferation and survival of triple-negative cells through control of B-Myb and EZH2

AU - Kalashnikova, Ekaterina V.

AU - Revenko, Alexey S.

AU - Gemo, Abigael T.

AU - Andrews, Nicolas P.

AU - Tepper, Clifford G

AU - Zou, June X

AU - Cardiff, Robert

AU - Borowsky, Alexander D

AU - Chen, Hongwu

PY - 2010/11/15

Y1 - 2010/11/15

N2 - Chromatin coregulators are important factors in tumorigenesis and cancer progression. ANCCA is an AAA+ ATPase and a bromodomain-containing nuclear coactivator for the estrogen and androgen receptors that is crucial for assembly of chromatin-modifying complexes and proliferation of hormone-responsive cancer cells. In this study, we show that ANCCA is overexpressed in >70% of breast tumors and that its high protein level correlates well with tumor histologic grades (P < 0.0001), highlighting ANCCA as a prognostic factor for poor overall survival and disease recurrence. Strikingly, high-level ANCCA correlated with triple-negative tumors that represent highly aggressive disease. Analysis of ANCCA transcript levels in multiple expression profiles of breast cancer identified ANCCA as a common signature gene, indicating that elevated transcripts also strongly correlate with tumor metastasis and poor survival. Biological and mechanistic investigations revealed that ANCCA is crucial for proliferation and survival of triple-negative/basal-like cancer cells and that it controls the expression of B-Myb, histone methyltransferase EZH2, and an Rb-E2F core program for proliferation, along with a subset of key mitotic kinesins and cell survival genes (IRS2, VEGF, and Akt1). In particular, ANCCA overexpression correlated strongly with EZH2 in tumors. Our results suggest that ANCCA may integrate multiple oncogenic programs in breast cancer, serving in particular as a prognostic marker and a therapeutic target for triple-negative cancers.

AB - Chromatin coregulators are important factors in tumorigenesis and cancer progression. ANCCA is an AAA+ ATPase and a bromodomain-containing nuclear coactivator for the estrogen and androgen receptors that is crucial for assembly of chromatin-modifying complexes and proliferation of hormone-responsive cancer cells. In this study, we show that ANCCA is overexpressed in >70% of breast tumors and that its high protein level correlates well with tumor histologic grades (P < 0.0001), highlighting ANCCA as a prognostic factor for poor overall survival and disease recurrence. Strikingly, high-level ANCCA correlated with triple-negative tumors that represent highly aggressive disease. Analysis of ANCCA transcript levels in multiple expression profiles of breast cancer identified ANCCA as a common signature gene, indicating that elevated transcripts also strongly correlate with tumor metastasis and poor survival. Biological and mechanistic investigations revealed that ANCCA is crucial for proliferation and survival of triple-negative/basal-like cancer cells and that it controls the expression of B-Myb, histone methyltransferase EZH2, and an Rb-E2F core program for proliferation, along with a subset of key mitotic kinesins and cell survival genes (IRS2, VEGF, and Akt1). In particular, ANCCA overexpression correlated strongly with EZH2 in tumors. Our results suggest that ANCCA may integrate multiple oncogenic programs in breast cancer, serving in particular as a prognostic marker and a therapeutic target for triple-negative cancers.

UR - http://www.scopus.com/inward/record.url?scp=78549291781&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78549291781&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-10-1199

DO - 10.1158/0008-5472.CAN-10-1199

M3 - Article

C2 - 20864510

AN - SCOPUS:78549291781

VL - 70

SP - 9402

EP - 9412

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 22

ER -